new cd22 car t-cells for pediatric r/r b-all are highly effective
Published 6 years ago • 305 plays • Length 4:23Download video MP4
Download video MP3
Similar videos
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status
-
3:23
phase i study of cd22 car-t therapy in patients with lbcl who have relapsed after cd19 car-t therapy
-
1:52
opportunities and challenges for dual-targeting car-t therapy in all
-
2:32
phase i study of cd22-targeted car-t therapy in patients with cd19-negative b-all
-
3:33
car t-cells for all
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
1:49
car-t cell approaches in cll: current progress & future directions
-
1:55
developing the next generation of car-t cells
-
1:29
new hnhcp car-t therapy guidelines: an educational resource for nurses and hcps
-
1:27
car t-cells in all: an overview
-
3:34
humanized versus murinized cd19/cd22 car-t cell therapy for r/r b-cell lymphoma
-
1:58
car t-cell therapy and all: the current landscape
-
1:33
the patient's voice in car t-cell regulatory processes
-
1:56
the state of car t-cell products today
-
1:09
the evolution of car t-cell therapy
-
1:24
educational material for hcps on car t-cell therapy
-
1:02
the use of car-t cell products in a real-world setting